See Asa at Microbiome & Probiotic R&D & Business Collaboration Forum - La Jolla, California 10/13/2025
September 25, 2024
Takeaway -

When will FDA go after “Nature’s Ozempic” claims

September 18, 2024
Takeaway -

Do not over-explain clinical research

September 11, 2024
Takeaway -

Blogs are “labeling”

September 4, 2024
Takeaway -

Disease claims trigger deeper FDA review

August 28, 2024
Takeaway -

Cosmetics are not "FDA-approved"

August 21, 2024
Takeaway -

Even lower risk statements can trigger NAD scrutiny

August 14, 2024
Takeaway -

Copackers & distributors must comply with GMPs

August 7, 2024
Takeaway -

Flu & virus claims are enough for regulatory action

July 31, 2024
Takeaway -

Specifications continue to be cited

July 17, 2024
Takeaway -

Unsafe products marketed to children are deceptive

July 10, 2024
Takeaway -

Food safety plans should be comprehensive

July 3, 2024
Takeaway -

Review of NAD case